The landscape of clinical trials focusing on melanoma, a prominent type of skin cancer, is marked by an engaging dynamism. Current efforts primarily hinge on targeted treatments and immune therapies. Researchers are striving for in-depth understanding and identification of genetic mutations driving melanoma, which have led to several FDA-approved treatments....
Discover more insightsThe advent of numerous high-efficacy products has witnessed a dramatic transformation of the melanoma market landscape. Supported by significant investments in research and development (R&D), these innovative treatments, primarily immune and targeted therapies, have shown promising results compared to the conventional chemotherapy treatments. However, this high innovation rate coupled with...
Discover more insightsRecent advancements have taken place in the field of non-melanoma skin cancer diagnosis. These include non-invasive imaging modalities like dermoscopy, confocal microscopy, and optical coherence tomography. Biopsy, once considered the only definitive diagnostic tool, is being complemented by these less invasive techniques, leading to early detection and less patient discomfort.
Discover more insights